ARWR · All filings · Read this filing
What changed 10-K
Item 5. Market for Registrant’s Common Equity
2024-11-26 compared with 2023-11-29 · 3 added, 2 removed, 15 unchanged (25% of the section changed)
4 unchanged sentences
Recent Sales of Unregistered Securities
+Added: To the extent required by Form 10-K, the disclosures set forth in Part II, Item 9B of this Annual Report on Form 10-K under the headings “Stock Purchase Agreement” and “Securities Purchase Agreement” are incorporated herein by reference.
Repurchases of Equity Securities
8 unchanged sentences
ARWR $ 100.00 $ 152.80 $ 221.54 $ 117.28 $ 95.35 $ 68.74
−Removed: NASDAQ Biotechnology Index ^NBI $ 100.00 $ 81.55 $ 110.98 $ 132.58 $ 98.23 $ 103.08
−Removed: NASDAQ Composite Index ^IXIC $ 100.00 $ 99.42 $ 138.79 $ 179.57 $ 131.43 $ 164.29
+Added: NASDAQ Biotechnology Index ^NBI $ 100.00 $ 136.10 $ 162.58 $ 120.46 $ 126.41 $ 152.44
+Added: NASDAQ Composite Index ^IXIC $ 100.00 $ 139.61 $ 180.62 $ 132.21 $ 165.26 $ 227.38
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.